Here you can find news from MPG spin-off companies.
Evotec Starts Clinical Development of Chikungunya Antibody together with NIAID and Leading Academic Research Organisation
MorphoSys AG: MorphoSys and I-Mab Announce First Patient Dosed in U.S. Phase 1 Study of MOR210/TJ210 in Patients with Advanced Cancer
MorphoSys and Incyte Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab
Alnylam Launches Alnylam P⁵x25 Strategy for Planned Transition to a Top Five Biotech in Market Capitalization Over Next Five Years
Alnylam Reports Positive Topline Results from HELIOS-A Phase 3 Study of Vutrisiran in Patients with hATTR Amyloidosis with Polyneuropathy